FMP

FMP

Enter

MAB.WA - Mabion S.A.

photo-url-https://images.financialmodelingprep.com/symbol/MAB.WA.png

Mabion S.A.

MAB.WA

WSE

Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland.

10.3 PLN

-0.08 (-0.777%)

Valuation Date:

Mar 21, 2025 12:00 PM

Share Price on Valuation Date

$10.3

Stock Beta

0.993

Shares Outstanding

16162299

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep